HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei Yu Selected Research

Castration

1/2021Potent antitumour of the mTORC1/2 dual inhibitor AZD2014 in docetaxel-sensitive and docetaxel-resistant castration-resistant prostate cancer cells.
1/2021Identification of Novel Diagnosis Biomarkers for Therapy-Related Neuroendocrine Prostate Cancer.
1/2021Novel Androgen Receptor Inhibitors in Non-Metastatic, Castration-Resistant Prostate Cancer: A Systematic Review and Network Meta-Analysis.
1/2021SPP1 Promotes Enzalutamide Resistance and Epithelial-Mesenchymal-Transition Activation in Castration-Resistant Prostate Cancer via PI3K/AKT and ERK1/2 Pathways.
1/2019Exposure-Response-Based Product Profile-Driven Clinical Utility Index for Ipatasertib Dose Selection in Prostate Cancer.
8/2015[Predictor analysis of PSA response of docetaxel combined with prednisone in the treatment of metastatic castration resistant prostate cancer].
7/2013ERK and AKT signaling drive MED1 overexpression in prostate cancer in association with elevated proliferation and tumorigenicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wei Yu Research Topics

Disease

195Neoplasms (Cancer)
05/2024 - 01/2003
58Inflammation (Inflammations)
04/2024 - 11/2010
49Infections
05/2024 - 04/2003
26Neoplasm Metastasis (Metastasis)
05/2024 - 05/2003
24Prostatic Neoplasms (Prostate Cancer)
10/2023 - 03/2004
23Hepatocellular Carcinoma (Hepatoma)
11/2023 - 03/2008
22Breast Neoplasms (Breast Cancer)
01/2023 - 05/2003
21Carcinogenesis
01/2024 - 03/2004
21Carcinoma (Carcinomatosis)
01/2024 - 03/2010
19Atherosclerosis
05/2024 - 04/2002
18Osteoporosis
05/2024 - 09/2002
18Osteosarcoma (Osteogenic Sarcoma)
03/2024 - 06/2017
16Hypertension (High Blood Pressure)
02/2024 - 11/2007
16Sepsis (Septicemia)
01/2024 - 01/2018
16Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2023 - 04/2011
15Fibrosis (Cirrhosis)
02/2024 - 07/2011
15Colitis
04/2023 - 05/2019
14Hypoxia (Hypoxemia)
11/2023 - 01/2009
14Colorectal Neoplasms (Colorectal Cancer)
11/2023 - 08/2010
14Hemorrhage
04/2023 - 08/2008
13Glioma (Gliomas)
12/2023 - 05/2006
12Type 2 Diabetes Mellitus (MODY)
02/2024 - 05/2013
11Renal Cell Carcinoma (Grawitz Tumor)
04/2024 - 09/2011
11Obesity
02/2024 - 10/2010
10Body Weight (Weight, Body)
11/2023 - 04/2005
10Lung Neoplasms (Lung Cancer)
09/2021 - 02/2013
9Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
03/2024 - 11/2007
9Virus Diseases (Viral Diseases)
12/2023 - 01/2018
9Stroke (Strokes)
12/2023 - 03/2007
9Wounds and Injuries (Trauma)
11/2023 - 05/2017
9Cardiovascular Diseases (Cardiovascular Disease)
10/2023 - 01/2009
9Urinary Bladder Neoplasms (Bladder Cancer)
10/2023 - 08/2011
9Ulcerative Colitis
11/2022 - 01/2017
8Aplastic Anemia (Anemia, Hypoplastic)
04/2024 - 09/2007
8COVID-19
11/2023 - 12/2020
8Insulin Resistance
11/2023 - 04/2009
8Pain (Aches)
10/2023 - 01/2015
8Stomach Neoplasms (Stomach Cancer)
01/2023 - 01/2015
8Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 11/2015
8Cysts
01/2009 - 01/2005
7Cardiotoxicity
04/2024 - 01/2017
7Myocardial Infarction
01/2023 - 01/2013
7Traumatic Brain Injuries (Traumatic Brain Injury)
01/2023 - 11/2012
7Poisoning
01/2021 - 04/2007
7Disease Progression
01/2021 - 03/2010
7Rheumatoid Arthritis
07/2020 - 12/2011
6Osteoarthritis
02/2024 - 07/2013
6Oncogenic osteomalacia
02/2024 - 07/2015
6Metabolic Bone Diseases (Osteopenia)
01/2024 - 09/2002

Drug/Important Bio-Agent (IBA)

66Proteins (Proteins, Gene)FDA Link
05/2024 - 04/2003
41Biomarkers (Surrogate Marker)IBA
03/2024 - 03/2004
21LipidsIBA
04/2024 - 08/2008
21RNA (Ribonucleic Acid)IBA
12/2023 - 01/2006
19MicroRNAs (MicroRNA)IBA
02/2023 - 09/2010
18CytokinesIBA
02/2024 - 05/2007
17Long Noncoding RNAIBA
02/2023 - 01/2014
15Messenger RNA (mRNA)IBA
03/2024 - 01/2006
15EnzymesIBA
08/2023 - 01/2006
14Dextrans (Dextran)FDA Link
04/2023 - 12/2015
13Small Interfering RNA (siRNA)IBA
05/2023 - 01/2006
13sodium sulfate (sodium bisulfate)FDA LinkGeneric
04/2023 - 12/2020
12Carbapenems (Carbapenem Antibiotics)IBA
01/2024 - 01/2018
11DNA (Deoxyribonucleic Acid)IBA
01/2024 - 01/2003
11Reactive Oxygen Species (Oxygen Radicals)IBA
10/2023 - 07/2010
10Therapeutic UsesIBA
04/2024 - 01/2006
10Uric Acid (Urate)IBA
09/2023 - 01/2020
10Estrogen ReceptorsIBA
01/2022 - 05/2003
10Transcription Factors (Transcription Factor)IBA
01/2022 - 04/2009
9Interleukin-17 (Interleukin 17)IBA
04/2024 - 01/2018
9VaccinesIBA
11/2023 - 11/2016
9Glucose (Dextrose)FDA LinkGeneric
11/2023 - 04/2009
9LigandsIBA
01/2023 - 03/2004
9AntigensIBA
01/2023 - 12/2015
9Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2011
8CalciumIBA
02/2024 - 09/2002
8Anti-Bacterial Agents (Antibiotics)IBA
01/2024 - 06/2015
8AlbuminsIBA
01/2024 - 01/2015
8Lysine (L-Lysine)FDA Link
11/2023 - 01/2021
8Peptides (Polypeptides)IBA
11/2023 - 03/2004
8Blood Glucose (Blood Sugar)IBA
11/2023 - 05/2013
8ErbB Receptors (EGF Receptor)IBA
10/2023 - 05/2011
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 01/2011
8Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2018 - 04/2011
7AntioxidantsIBA
04/2024 - 03/2015
7Indicators and Reagents (Reagents)IBA
03/2024 - 03/2013
7Fibroblast Growth Factor-23IBA
10/2023 - 07/2015
7Vitamin DFDA LinkGeneric
01/2023 - 12/2002
7CateninsIBA
10/2021 - 01/2017
7Docetaxel (Taxotere)FDA Link
01/2021 - 09/2008
6CholesterolIBA
04/2024 - 01/2015
6Estrogens (Estrogen)FDA Link
03/2024 - 12/2002
6Insulin (Novolin)FDA Link
02/2024 - 04/2009

Therapy/Procedure

95Therapeutics
05/2024 - 03/2004
23Radiotherapy
05/2024 - 08/2012
23Drug Therapy (Chemotherapy)
01/2024 - 09/2008
13Immunotherapy
01/2023 - 09/2007
11Prostatectomy (Retropubic Prostatectomy)
12/2023 - 09/2008
8Cystectomy
04/2020 - 08/2011
7Castration
01/2021 - 07/2013
7Highly Active Antiretroviral Therapy (HAART)
08/2017 - 04/2009